Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Parkinson´s Disease”

251 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 251 results

Not applicableLooking for participantsNCT05539196
What this trial is testing

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Who this might be right for
Movement DisordersNeurologyParkinsons Disease
InSightec 60
Early research (Phase 1)Study completedNCT00115427
What this trial is testing

Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Amgen
Not applicableStudy completedNCT01470859
What this trial is testing

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Huashan Hospital 30
Not applicableTemporarily pausedNCT03074812
What this trial is testing

Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation

Who this might be right for
Idiopathic Parkinson's DiseaseParkinson DiseaseDepression
Johns Hopkins University 80
Testing effectiveness (Phase 2)Study completedNCT00407212
What this trial is testing

Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Who this might be right for
Parkinson's Disease
Novartis 301
Large-scale testing (Phase 3)Study completedNCT00594165
What this trial is testing

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Who this might be right for
Early-Stage Parkinson's Disease
UCB Pharma 217
Testing effectiveness (Phase 2)Study completedNCT05931575
What this trial is testing

Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson´s Disease
Technical University of Munich 81
Not applicableLooking for participantsNCT06174948
What this trial is testing

The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders

Who this might be right for
Parkinson's Disease and ParkinsonismProgressive Supranuclear PalsyDifferent Types of Tremor Including Essential Tremor+5 more
Queen Mary University of London 70
Large-scale testing (Phase 3)Study completedNCT01227655
What this trial is testing

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 427
Not applicableStudy completedNCT00368199
What this trial is testing

Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes

Who this might be right for
Parkinson's DiseaseParkinsonian SyndromeMultiple System Atrophy+4 more
Maastricht University Medical Center 196
Early research (Phase 1)Not Yet RecruitingNCT05094011
What this trial is testing

Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Taiwan Mitochondrion Applied Technology Co., Ltd. 9
Not applicableStudy completedNCT04524182
What this trial is testing

The Acute Effect of Lumbosacral Mobilization in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Hacettepe University 28
Not applicableStudy completedNCT01159691
What this trial is testing

Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal Patch

Who this might be right for
Idiopathic Parkinson's Disease
UCB Pharma GmbH 76
Testing effectiveness (Phase 2)Study completedNCT00160576
What this trial is testing

Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

Who this might be right for
Idiopathic Parkinson Disease
UCB Pharma 30
Testing effectiveness (Phase 2)Study completedNCT01617135
What this trial is testing

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 25
Not applicableStudy completedNCT05976971
What this trial is testing

Microstructural and Sodium 7 Tesla Brain MRI in Idiopathic REM Sleep Behaviour Disorder

Who this might be right for
REM Sleep Behaviour Disorder
Assistance Publique Hopitaux De Marseille 31
Testing effectiveness (Phase 2)Study completedNCT03257046
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease

Who this might be right for
Parkinson Disease
Intra-Cellular Therapies, Inc. 40
Early research (Phase 1)Study completedNCT02565628
What this trial is testing

PF-06669571 In Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT02462603
What this trial is testing

Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Edison Pharmaceuticals Inc 44
Not applicableStudy completedNCT05795023
What this trial is testing

A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

Who this might be right for
Parkinson Disease
NeuraLight 30
Next Page